GSK's CEO Emma Walmsley will step down in December and be replaced by insider Luke Miels, the British drugmaker said on ...

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more ...

(Reuters) -British drugmaker GSK said on Monday Emma Walmsley will step down as CEO after nine years in the role and will be ...

GSK CEO Dame Emma Walmsley will step down at the end of 2025 and be succeeded by Luke Miels, who will lead the company into a ...

GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on ...

Emma Walmsley, who in 2017 became the first woman to lead a major pharmaceutical company, will step down from her post as CEO ...

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the ...

GSK named Luke Miels to succeed Emma Walmsley as the British drugmaker’s CEO. - chris j ratcliffe/Reuters GSK said Emma ...

Walmsley, who helped push GSK to focus more exclusively on specialty medicines and oncology, will be succeeded by commercial ...

Walmsley will step down from the board of directors of GSK at the end of the year, and will step down as CEO on 30th ...

Chief executive Emma Walmsley is to leave GSK, it was announced on Monday, after nearly a decade in the role. She will be ...

GSK names Luke Miels as next CEO, succeeding Emma Walmsley at a pivotal time as the drugmaker sets ambitious growth targets ...